Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ARKKBearishIndustry Newsnews

High materiality7/10

ARKK underperforms QQQ; healthcare/AI tilt drives ongoing divergence

Oct 6, 2026, 4:34 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Persistent underperformance relative to QQQ, plus a prominent focus on ARKK's healthcare/AI tilt could pressure near-term sentiment and fund flows; historical cases show performance gaps can trigger outflows and valuation re-rating before long-term cycle shifts.

AI summary

What happened, with direct paths to the underlying reporting

ARKK trails QQQ by five years as ARK emphasizes disruptive healthcare AI, a divergence Wood attributes to endpoint sensitivity and mandate differences. October 2026 holdings show a ~28% healthcare weight, highlighting ARKK's unique risk/return profile versus QQQ's tech concentration and broader exposure. The debate underscores the fund's longer-horizon thesis and potential for repositioning or inflows/outflows depending on performance context.

ARKK down 14.91% over five years. QQQ up 111.60%.
Wood says five-year figures are endpoint sensitive. ARK vs QQQ is not comparable.
ARKK ~28-30% in healthcare/biotech; major positions TEM, CRSP, TWST.
ARKK strategy centers on disruptive innovation across sectors vs QQQ's Nasdaq-100.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

ARKK underperforms QQQ; healthcare/AI tilt drives ongoing divergence

Growing Opportunities for OpenAI Exposure Likely to Benefit ARKK

Cathie Wood Beats S&P 500 in 2025 — This ARK ETF Delivered The Knockout With A 50% Gain

Is Gold in the Grips of a Speculative Bubble?

This under-the-radar ETF trend may be flashing a warning signal for the market